Applied BioMath, LLC to Present at PEGS Summit
News provided by
Share this article
CONCORD, Mass., May 4, 2021 /PRNewswire/ Applied BioMath (
www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development today announced their participation at the PEGS Summit occurring virtually May 11-13, 2021.
John Burke, PhD, Co-founder, President and CEO of Applied BioMath will present Applied BioMath Assess™ - An Early Feasibility Assessment Tool for Biotherapeutics within the conference program, Advancing Bispecific Antibodies and Combination Therapy to the Clinic on Tuesday, May 11th at 10:40 a.m. ET. In this presentation, Dr. Burke will demonstrate how Applied BioMath s new and interactive software tool systematically investigates the therapeutic characteristics (e.g., format, half-life, affinity, mechanism of action) given target characteristics (e.g., target expression and